These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
218 related items for PubMed ID: 31267879
1. Three Pt-Pt Complexes with Donor-acceptor Feature: Anticancer Activity, DNA Binding Studies and Molecular Docking Simulation. Ashoo P, Yousefi R, Nabavizadeh SM, Aseman MD, Paziresh S, Ghasemi A, Saboury AA. Anticancer Agents Med Chem; 2019; 19(14):1762-1774. PubMed ID: 31267879 [Abstract] [Full Text] [Related]
2. Anticancer Activity Assessment and DNA Binding Properties of Two Binuclear Platinum (II) Complexes using Spectroscopic and Molecular Simulation Approaches. Alavianmehr MM, Ashrafi A, Yousefi R, Haghighi MG, Abolmaali SS, Moosavi-Movahedi AA, Rad MNS. Anticancer Agents Med Chem; 2020; 20(17):2066-2073. PubMed ID: 32628598 [Abstract] [Full Text] [Related]
8. Homo- and heteroleptic Pt(II) complexes of ONN donor hydrazone and 4-picoline: A synthetic, structural and detailed mechanistic anticancer investigation. Rahman FU, Bhatti MZ, Ali A, Duong HQ, Zhang Y, Yang B, Koppireddi S, Lin Y, Wang H, Li ZT, Zhang DW. Eur J Med Chem; 2018 Jan 01; 143():1039-1052. PubMed ID: 29232581 [Abstract] [Full Text] [Related]
9. Synthesis, spectroscopic and biological studies of a fluorescent Pt(II) (terpy) based 1,8-naphthalimide conjugate as a DNA targeting agent. Banerjee S, Kitchen JA, Bright SA, O'Brien JE, Williams DC, Kelly JM, Gunnlaugsson T. Chem Commun (Camb); 2013 Oct 04; 49(76):8522-4. PubMed ID: 23942760 [Abstract] [Full Text] [Related]
10. Half-Lantern Cyclometalated Platinum(II) Complexes as Anticancer Agents: Molecular Docking, Apoptosis, Cell Cycle Analysis, and Cytotoxic Activity Evaluations. Hajipour F, Mahdavinia M, Fereidoonnezhad M. Anticancer Agents Med Chem; 2022 Oct 04; 22(6):1149-1158. PubMed ID: 34259151 [Abstract] [Full Text] [Related]
15. Anticancer activity assessment of two novel binuclear platinum (II) complexes. Shahsavani MB, Ahmadi S, Aseman MD, Nabavizadeh SM, Rashidi M, Asadi Z, Erfani N, Ghasemi A, Saboury AA, Niazi A, Bahaoddini A, Yousefi R. J Photochem Photobiol B; 2016 Aug 04; 161():345-54. PubMed ID: 27289447 [Abstract] [Full Text] [Related]
16. Novel diindoloazepinone derivatives as DNA minor groove binding agents with selective topoisomerase I inhibition: Design, synthesis, biological evaluation and docking studies. Kadagathur M, Devi GP, Grewal P, Sigalapalli DK, Makhal PN, Banerjee UC, Bathini NB, Tangellamudi ND. Bioorg Chem; 2020 Jun 04; 99():103629. PubMed ID: 32272367 [Abstract] [Full Text] [Related]
17. New bio-sensitive and biologically active single crystal of pyrimidine scaffold ligand and its gold and platinum complexes: DFT, antimicrobial, antioxidant, DNA interaction, molecular docking with DNA/BSA and anticancer studies. Sankarganesh M, Dhaveethu Raja J, Sakthikumar K, Solomon RV, Rajesh J, Athimoolam S, Vijayakumar V. Bioorg Chem; 2018 Dec 04; 81():144-156. PubMed ID: 30121002 [Abstract] [Full Text] [Related]
18. Morpholine or methylpiperazine and salicylaldimine based heteroleptic square planner platinum (II) complexes: In vitro anticancer study and growth retardation effect on E. coli. Rahman FU, Ali A, Khan IU, Duong HQ, Yu SB, Lin YJ, Wang H, Li ZT, Zhang DW. Eur J Med Chem; 2017 May 05; 131():263-274. PubMed ID: 28334655 [Abstract] [Full Text] [Related]